A case of hyoscine-related oesophagitis.
We describe a previously unreported association between hyoscine hydrobromide and severe oesophagitis, with ulceration visible almost to the submucosa in the distal oesophagus. The condition resolved with cessation of tablets and 2 months' treatment with a proton-pump inhibitor.
Philcox
Stephen
S
Department of Gastroenterology, Nepean Hospital, Sydney, NSW, Australia. drsmp@internode.on.net
Keegan
Andrew
A
D015746:Abdominal Pain / Q000209:etiology; D000284:Administration, Oral; D000328:Adult; D003937:Diagnosis, Differential; D004941:Esophagitis / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D005773:Gastroscopy; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects*
D018727:Muscarinic Antagonists; D012601:Scopolamine